SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-027772
Filing Date
2023-10-05
Accepted
2023-10-05 16:30:25
Documents
14
Period of Report
2023-10-02
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20231004_8k.htm   iXBRL 8-K 30856
2 EXHIBIT 16.1 ex_576629.htm EX-16.1 3012
  Complete submission text file 0001437749-23-027772.txt   168145

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acrx-20231002.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20231002_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20231002_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20231002_pre.xml EX-101.PRE 11584
8 EXTRACTED XBRL INSTANCE DOCUMENT acrx20231004_8k_htm.xml XML 2566
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 231311716
SIC: 2834 Pharmaceutical Preparations